CARBIDOPA, LEVODOPA AND ENTACAPONE

481 reported adverse events

Drug classes: Aromatic Amino Acid Decarboxylation Inhibitor [EPC] Aromatic Amino Acid [EPC] Catechol-O-Methyltransferase Inhibitor [EPC]

These side effects are most commonly reported by patients taking CARBIDOPA, LEVODOPA AND ENTACAPONE:

# Side effect Count
0 FALL 69
1 DEATH 54
2 HALLUCINATION 52
3 DRUG INEFFECTIVE 43
4 PARKINSON^S DISEASE 41
5 DYSKINESIA 27
6 URINARY TRACT INFECTION 27
7 PRODUCT DOSE OMISSION ISSUE 25
8 CONFUSIONAL STATE 24
9 DEVICE ISSUE 21
See all common reactions for CARBIDOPA, LEVODOPA AND ENTACAPONE

CARBIDOPA, LEVODOPA AND ENTACAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADRENAL MEDULLA HYPERFUNCTION 1 1.0000
1 STOMA SITE CANDIDA 2 0.0741
2 STOMA SITE DERMATITIS 2 0.0606
3 PYLORUS DILATATION 1 0.0500
4 HYPOINSULINAEMIA 1 0.0345
5 GASTROLITHIASIS 1 0.0333
6 MEDICAL DEVICE SITE DISCOLOURATION 1 0.0233
7 MEDICAL DEVICE SITE ULCER 1 0.0208
8 STOMA SITE EXTRAVASATION 8 0.0207
9 STOMA SITE ABSCESS 3 0.0123
See all enriched reactions for CARBIDOPA, LEVODOPA AND ENTACAPONE